Markets › Stocks › NECLIFE
NE

Nectar Lifesciences Ltd

NSE: NECLIFEBSE: 532649Healthcare
₹11.98
▼ -0.91%
NSE · 15-min delayed
Prev Close
₹24.36
Day High
₹12.21
Day Low
₹11.85
Mkt Cap
₹242 Cr
P / E
-
P / B
0.4
ROE
-50.3%
52W High
₹25.53
52W Low
₹9.20
Key Metrics
Market Cap
₹242 Cr
P / E
-
P / B
0.4
ROCE
-7.3%
ROE
-50.3%
Div Yield
-
Revenue · ₹ Cr
2.4k
FY20
1.5k
FY21
1.7k
FY22
1.5k
FY23
1.7k
FY24
1.7k
FY25
9
FY26
Net Profit · ₹ Cr
32
FY20
-73
FY21
25
FY22
-24
FY23
5
FY24
-114
FY25
-293
FY26
EPS · ₹ per share
₹2.6
FY16
₹2.1
FY19
₹1.4
FY20
₹-3.3
FY21
₹1.1
FY22
₹-1.1
FY23
₹0.2
FY24
P / E Ratio · price ÷ TTM EPS
0279557836011Jun 21Jan 23Oct 24Jun 26
P/E 15.8×Median 111.0×TTM EPS
Q1 2026 snapshot
Sales
₹8 Cr
Operating profit
-
OPM
-
Net profit
₹-68 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
-
Growth
Bad
-21.2%
Profitability
Bad
-28.8%
Performance
Bad
-50.7%
Entry Point
Strong
47%
Red Flags
Strong
0 flags
Shareholding Pattern
51.8%Promoter
Promoter51.8%
FII0.6%
DII4.0%
Public43.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue454.982430.77281.025.740.667.58
Net Profit7.84-130.089-63.231-176.00614.27-67.924
NPM %1.7%-30.2%-22.5%-3066.3%2162.1%-896.1%
AlertPre-trade